Anticoagulation versus placebo for heart failure in sinus rhythm (Q24202686)

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

The natural history of idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

Recognising the limits of randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

The effect of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

7 January 2021

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

7 January 2021

Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

7 January 2021

Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

7 January 2021

Dicumarol therapy in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

7 January 2021

Dicumarol prophylaxis of thromboembolic disease in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

7 January 2021

Ventricular dysfunction and the risk of stroke after myocardial infarction

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

7 January 2021

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

7 January 2021

A study of the beneficial effects of anticoagulant therapy in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003336.PUB2

7 January 2021